Back Lung cancer


For lung cancer, it is essential to have a multidisciplinary therapeutic plan that combines surgery, radiation therapy and chemotherapy, depending on the needs of each patient.

The success of these healthcare areas lies precisely in teamwork, the design of joint protocols, the interaction between medical teams and the flexibility of care, which enables the work groups to be composed of specialists from multiple areas.

The joint efforts of pulmonologists, radiation oncologists, pathologists, radiologists, nuclear medicine specialists and oncologists dedicated to the diagnosis and treatment of chest tumours increase the quality of care.


Imagen con los pasos que hay que dar para solicitar una segunda opinión en la Clínica Universidad de Navarra

If you require the opinion of our experts without having to travel to the Clinica, we offer the possibility of a Second Medical Opinion consultation.

When the lung cancer is localised, a surgical approach is possible in a high percentage of cases.

If the disease is disseminated, it is likely that surgery will not be possible. To determine whether surgery is possible, respiratory function tests need to be conducted to determine whether the respiratory reserve that remains after surgery will be sufficient for the patient to continue breathing.

Surgical procedures:

  • Lobectomy: extirpation of a lung lobe. Applicable to patients with sufficient respiratory reserve. Minimises the probability of a localised recurrence.
  • Pneumonectomy: extirpation of the entire lung.
  • Segmentectomy or wedge resection: extirpation of part of a lobe. This is performed in patients with reduced respiratory function.

If the lung cancer has spread to the brain, it is possible that extirpation of the brain metastases (metastasectomy) will be beneficial, provided it does not damage the brain.

Currently, a less invasive procedure is applied to treat early-stage lung cancer: videothoracoscopy, which consists of placing a small camera in the chest cavity enabling the surgeon to see the tumour. Therefore, the incisions that are performed are smaller and recovery is quicker.

There are two different treatments, depending on whether or not the carcinoma is small cell 

Small cell carcinomas, which make up 20% of lung tumours, are usually more aggressive and have a greater tendency to disseminate to other regions early on and, therefore, have a less favourable prognosis. They are treated with chemotherapy from the start and as soon as possible.

The prognosis is better for patients in whom the disease is located early. Additionally, radiation should be administered to the chest region where the tumour is located, along with holocranial radiation therapy to prevent the disease from spreading to the brain. In these cases, the treatments dramatically improve the patient's quality of life and extend their survival.

In non-small cell carcinomas, chemotherapy can be applied before or after surgery, depending on the characteristics of the cancer and its degree of dissemination.

We have biological agents that act on specific molecular targets of the tumour, personalising the treatment of non-small cell lung cancer based on molecular analysis of each patient’s tumour.

Radiation therapy for non-small cell cancer, vital for controlling the disease

It can be used as a preoperative treatment to reduce the size of the tumour so that it can be eliminated with surgery. 

For tumours that cannot be treated with surgery or non-extended non-small cell carcinomas, high-dose radiation therapy can be administered or combined with chemotherapy based only on cisplatin or with other chemotherapy agents such as paclitaxel.

Postoperative radiation is considered for lung tumours that have been operated in which involvement of the mediastinal lymph nodes is confirmed or in cases in which involvement of the resection margins has been documented.

Radiation treatment of lung carcinomas represents a medical challenge because the lung has a very limited tolerance to radiation. The proximity of organs, such as the spinal cord, heart and oesophagus, requires the use of highly selective radiation techniques if radical radiation treatment is to be administered.

For small lung tumours (smaller than 3 cm) in patients who are medically inoperable, stereotactic radiation therapy can also be administered, given that it offers excellent control results with very few adverse effects.



Learn why the Clínica Universidad de Navarra is different from other hospitals.

Imagen de una niña pequeña con cáncer por los pasillos de la Clínica


Want to participate in our clinical trials? Learn which ones are active.

Imagen médico investigando con microscopio


Know what we do for our international patients

Entrada principal a la Clínica Universidad de Navarra